12:00 AM
 | 
Dec 23, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

NeuraCeq [18F]-florbetaben regulatory update

EMA's CHMP issued a positive opinion recommending approval of an MAA for NeuraCeq [18F]-florbetaben for PET imaging of beta amyloid neuritic plaque density in adults with cognitive impairment who are being...

Read the full 141 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >